Search research articles
Contact Us
Filters
Showing results (321-330 of 326) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 326 results.
Journal of Medicinal Chemistry
|
March 3, 2020
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents
Daniel L Priebbenow, David J Leaver, Nghi Nguyen, et al.
Cancer Discovery
|
June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
Shellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Nature
|
December 13, 2019
HBO1 is required for the maintenance of leukaemia stem cells
Laura MacPherson, Juliana Anokye, Miriam M Yeung, et al.
Nature
|
August 3, 2018
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
Jonathan B Baell, David J Leaver, Stefan J Hermans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 22, 2022
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Giulia Martina Cavestro, Alessandro Mannucci, Francesc Balaguer, et al.
Cell Chemical Biology
|
August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
Shikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 326) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 326 results.
Journal of Medicinal Chemistry
|
March 3, 2020
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents
Daniel L Priebbenow, David J Leaver, Nghi Nguyen, et al.
Cancer Discovery
|
June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia
Shellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Nature
|
December 13, 2019
HBO1 is required for the maintenance of leukaemia stem cells
Laura MacPherson, Juliana Anokye, Miriam M Yeung, et al.
Nature
|
August 3, 2018
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
Jonathan B Baell, David J Leaver, Stefan J Hermans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 22, 2022
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Giulia Martina Cavestro, Alessandro Mannucci, Francesc Balaguer, et al.
Cell Chemical Biology
|
August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
Shikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Page
of 33